Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report

RATIONALE: Antimelanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab)-positive clinically amyopathic dermatomyositis (cADM) is frequently complicated with interstitial lung disease (ILD) and has a poor prognosis. Although the short-term prognosis of anti-MDA5 Ab-positive cADM is poor, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Yuichi, Kasuya, Tadamichi, Fujiwara, Michio, Kita, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489601/
https://www.ncbi.nlm.nih.gov/pubmed/32925726
http://dx.doi.org/10.1097/MD.0000000000021943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489601/
https://www.ncbi.nlm.nih.gov/pubmed/32925726
http://dx.doi.org/10.1097/MD.0000000000021943

Ejemplares similares